Planned Parenthood of Southern New England, INC.

Planned Parenthood of Southern New England, INC. was paid $38.09M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	211,834	$5.85M
2019	223,039	$6.33M
2020	162,763	$4.89M
2021	199,908	$6.06M
2022	172,438	$5.05M
2023	214,869	$4.71M
2024incomplete	158,590	$5.21M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	17%	130,095	111,876	$6.45M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	15%	171,934	146,719	$5.73M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	15%	171,821	146,698	$5.73M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	11%	146,929	135,571	$4.33M
S4993	Contraceptive pills for birth control	9.0%	69,924	59,534	$3.44M
J1050	Injection, medroxyprogesterone acetate, 1 mg	6.2%	44,961	38,335	$2.35M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.3%	25,318	21,990	$2.01M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.7%	31,182	27,611	$1.02M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	2.4%	59,808	50,060	$914K
A4267	Contraceptive supply, condom, male, each	2.2%	67,947	62,729	$829K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	1.9%	11,490	9,466	$729K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	1.9%	14,816	13,526	$723K

52 more codes

81025		1.3%	72,264	$505K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	1.2%	6,198	$457K
99156		1.0%	11,531	$382K
36415	Collection of venous blood by venipuncture	<1%	96,472	$378K
99203	Doctor's office visit, new patient (routine)	<1%	4,265	$362K
S5001	Prescription drug, brand name	<1%	11,068	$327K
87210		<1%	48,329	$225K
S5000	Prescription drug, generic	<1%	18,586	$196K
85018		<1%	41,073	$102K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,519	$98K
87481		<1%	3,309	$96K
59840		<1%	1,738	$89K
81513		<1%	1,242	$83K
96127		<1%	4,927	$73K
J7303	Contraceptive supply, hormone containing vaginal ring, each	<1%	1,028	$67K
86901		<1%	19,535	$62K
99204	Doctor's office visit, new patient (more involved)	<1%	381	$55K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	995	$29K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	544	$28K
99201		<1%	799	$22K
58300		<1%	517	$21K
81002		<1%	7,467	$21K
S0199	Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs	<1%	1,071	$18K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	53	$18K
99152		<1%	342	$17K
01966		<1%	456	$14K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,357	$12K
99442		<1%	230	$9K
J7295	Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each	<1%	438	$7K
11982		<1%	73	$7K
S0190	Mifepristone, oral, 200 mg	<1%	1,124	$5K
90656		<1%	241	$4K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	44	$4K
90686		<1%	229	$4K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	12	$4K
90651		<1%	13	$3K
90688		<1%	253	$2K
99385		<1%	15	$2K
58301		<1%	25	$2K
99215	Doctor's office visit, returning patient (complex)	<1%	16	$2K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	116	$2K
11981		<1%	12	$1K
96160		<1%	730	$1K
99000		<1%	16,510	$478.50
S0191	Misoprostol, oral, 200 mcg	<1%	1,521	$472.66
87625		<1%	15	$433.72
90756		<1%	13	$341.24
99408		<1%	12	$246.40
83986		<1%	11,868	$152.95
76998		<1%	265	$13.86
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	6,362	$7.50
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	13	$7.20

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSKINNER, AMANDA (CHIEF EXECUTIVE OFFICER)